Hostname: page-component-cd9895bd7-fscjk Total loading time: 0 Render date: 2024-12-22T15:41:28.228Z Has data issue: false hasContentIssue false
  • English
  • Français

Low prevalence of antibody to human parvovirus B19 in Singapore

Published online by Cambridge University Press:  19 October 2009

Y. Matsunaga ,
K. T. Goh ,
E. Utagawa  and
N. Muroi
Y. Matsunaga
Affiliation:
Department of Epidemiology, The National Institute of Health, 1–23–1 Toyama, Shinjuku, Tokyo 162
K. T. Goh
Affiliation:
Quarantine and Epidemiology Department, Ministry of the Environment, Singapore
E. Utagawa
Affiliation:
Department of Epidemiology, The National Institute of Health, 1–23–1 Toyama, Shinjuku, Tokyo 162
N. Muroi
Affiliation:
Plasma Fraction Center, The Japanese Red Cross Society
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

A seroepidemiological survey was conducted in Singapore to assess the prevalence of antibody to human parvovirus B19. Sera were collected from 600 healthy individuals between 6 months and over 50 years of age and tested for IgG antibody against B19 virus by antigen capture indirect immunosorbent assay. The overall seropositivity rate was 16·2%. All the children under 5 years of age were seronegative. Antibody prevalence increased gradually from 3·5% in school children (5–14 years of age) to 7·7% in age group 15–19 years and then to 10·3% in young adults (20–24 years of age). In the age group 25–34 years the prevalence was 28% and in the age group over 35 years 65% had parvovirus B19 antibody. The results of the survey indicate that there has been very low incidence of B19 virus infection in Singapore during the last two decades.

Type
Research Article
Information
Epidemiology & Infection , Volume 113 , Issue 3 , December 1994 , pp. 537 - 540
Copyright
Copyright © Cambridge University Press 1994

References

1.LJ, Anderson. Role of parvovirusB 19 in human disease. Paed Infect Dis J 1987; 6: 711–18Google Scholar
2.BJ, Cohen, MM, Buckley. The prevalence of antibody to human parvovirus B19 in England and Wales. J Med Microbiol 1988; 25: 151–3Google Scholar
3.TF, Schwarz, Roggerdorf, M, Deinhardt, F. Prevalence of parvovirus B19 infection: a seroepidemiological study. Dtsch Med Wochenschr 1987; 112: 1526–31Google Scholar
4.LJ, Anderson, Tsou, C, Parker, R et al. Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay. J Clin Microbiol 1986; 24: 522–6Google Scholar
5.Yamashita, K, Matsunaga, Y, Taylor-Wiedeman, J, Yamazaki, S. A significant age shift of the human parvovirus B19 antibody prevalence among young adults in Japan observed in a decade. Jpn J Med Sci Biol 1992; 45: 49–58CrossRefGoogle ScholarPubMed
6.KT, Goh, LYM, Wong, CJ, Oon, Kumarapathy, S. The prevalence of antibody to hepatitis A virus in Singapore. Asia-Pacific J Pub Hlth 1987; 1: 9–11Google Scholar
7.Committee on Epidemic Diseases. Seroprevalence of herpes simplex virus infection in Singapore. Epidem News Bulletin 1992; 18: 63–4Google Scholar
8.Committee on Epidemic Diseases. Seroepidemiology of cytomegalovirus infection in Singapore. Epidem News Bulletin 1992; 18: 19–21Google Scholar
9.PL, Ooi, KT, Goh, Doraisingham, S, AE, Ling. Prevalence of varicella-zoster virus infection in Singapore. Southeast Asian J Trop Med Pub Hlth 1992; 23: 22–5Google Scholar
10.Committee on Epidemic Diseases. Seroepidemiology of measles, mumps and rubella. Epidem News Bulletin 1991; 17: 25–6Google Scholar
11.KT, Goh, Doraisingham, S, JL, Tan, GN, Lim, SE, Chew. An outbreak of hand, foot and mouth disease in Singapore. Bull Wld Hlth Org 1982; 60: 965–9Google Scholar
12.Nunoue, T, Okochi, K, PP, Mortimer, BJ, Cohen. Human parvovirus (B19) and erythema infectiosum. J Paediatr 1985; 107: 38–40CrossRefGoogle ScholarPubMed
13.RP, de Freitas, Wong, D, Boswell, F et al. Prevalence of human parvovirus (B19) and rubellavirus infections in urban and remote rural areas in northern Brazil. J Med Virol 1990; 32: 203–8Google Scholar
14.JP, Nascimento, MM, Buckley, KE, Brown, BJ, Cohen. The prevalence of antibody to human parvovirus B19 in Rio de Janeiro, Brazil. Rev Inst Med trop Silo Paulo 1990; 32: 41–5Google Scholar
15.TF, Schwarz, LG, Gurtler, Zoulek, G, Deinhardt, F, Roggendorf, M. Seroprevalence of human parvovirus B19 infection in São Tomé and Principe. Malawi and Mascarene Islands. Zbl Bakt 1989; 271: 231–6Google Scholar
16.PHLS Working Party on Fifth Disease. Prospective study of human parvovirus (B19) infection in pregnancy. BMJ 1990; 300: 1166–70CrossRefGoogle Scholar